|
MARCH5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.602900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.543500E-03 |
| Normal-vs-Stage2 |
7.545900E-02 |
| Normal-vs-Stage3 |
5.774500E-04 |
| Normal-vs-Stage4 |
1.60893999999745E-05 |
| Stage1-vs-Stage2 |
9.531200E-01 |
| Stage1-vs-Stage3 |
1.228830E-01 |
| Stage1-vs-Stage4 |
1.319740E-02 |
| Stage2-vs-Stage3 |
3.530400E-01 |
| Stage2-vs-Stage4 |
8.260100E-02 |
| Stage3-vs-Stage4 |
2.131400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.800340E-03 |
| Normal-vs-AfricanAmerican |
2.222400E-01 |
| Normal-vs-Asian |
1.978130E-02 |
| Caucasian-vs-AfricanAmerican |
3.973600E-01 |
| Caucasian-vs-Asian |
8.198600E-01 |
| AfricanAmerican-vs-Asian |
5.707000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.352900E-04 |
| Normal-vs-Female |
2.380300E-03 |
| Male-vs-Female |
1.201550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.016200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.773700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.599100E-04 |
| Normal-vs-Age(81-100Yrs) |
7.804500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.767640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.809600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.548600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.523000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.720400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.041800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.150800E-01 |
| Classical-VS-Follicular |
3.137000E-01 |
| Classical-VS-Other |
6.447800E-01 |
| Classical-VS-Normal |
1.391500E-02 |
| Tall-VS-Follicular |
9.634000E-01 |
| Tall-VS-Other |
9.636600E-01 |
| Tall-VS-Normal |
9.537100E-03 |
| Follicular-VS-Other |
9.547800E-01 |
| Follicular-VS-Normal |
4.695900E-03 |
| Other-VS-Normal |
1.273390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.811400E-04 |
| Normal-vs-N1 |
2.357700E-03 |
| N0-vs-N1 |
5.544800E-01 |
|
|
